Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab.
Takahashi S, Narita S, Fujiyama N, Hatakeyama S, Kobayashi T, Kato R, Naito S, Sakatani T, Kashima S, Koizumi A, Yamamoto R, Nara T, Kanda S, Numakura K, Saito M, Obara W, Tsuchiya N, Ohyama C, Ogawa O, Habuchi T.
Takahashi S, et al. Among authors: fujiyama n.
Cancer Sci. 2022 Dec;113(12):4059-4069. doi: 10.1111/cas.15488. Epub 2022 Sep 24.
Cancer Sci. 2022.
PMID: 35848083
Free PMC article.